drugset
Drugs / CD.JEVAX™
last change Jun 2013 re-read 9 days ago

CD.JEVAX™

also known as SA14 14 2 vaccine
Developed for
Japanese encephalitis

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 3 NCT01396512 Comparator Jul 2011 → Mar 2013 Japanese encephalitis Sanofi Pasteur, a Sanofi Company Completed Met primary

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CD.JEVAX “Participants will receive a single dose of the Japanese encephalitis live attenuated vaccine (SA14 14 2 vaccine), CD.JEVAX™ on Day 0” NCT01396512 ↗
Known as SA14 14 2 vaccine “Japanese encephalitis live attenuated vaccine (SA14 14 2 vaccine), CD.JEVAX™” NCT01396512 ↗